Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats

Nephrology Dialysis Transplantation

Volumn 23, Issue 12, 2008, Pages 3824-3830

  Noonan, William ^a,e   Koch, Kristin ^a   Nakane, Masaki ^b   Ma, Junli ^a   Dixon, Doug ^c   Bolin, Antoinette ^a   Reinhart, Glenn ^d  

^a ABBOTT LABORATORIES   (United States)

^b Pharmaceutical Discovery   (United States)

^c Genusbiosystems   (United States)

^d BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^e GPRD   (United States)

Author keywords

Cardiovascular complications; Chronic kidney disease; Paricalcitol; Pulse wave velocity; Vascular calcification; Vitamin D receptor activator

Indexed keywords

CALCIUM; DOXERCALCIFEROL; PARATHYROID HORMONE; PARICALCITOL; PHOSPHORUS 32; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; VITAMIN D RECEPTOR ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CALCIFICATION; ARTICLE; BLOOD VESSEL CALCIFICATION; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DOPPLER FLOWMETRY; HYPERPARATHYROIDISM; IN VIVO STUDY; MALE; NEPHRECTOMY; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; PATHOGENESIS; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PULSE WAVE; RAT; SPRAGUE DAWLEY RAT; UREMIA;

ANIMALS; AORTA; BLOOD FLOW VELOCITY; CALCINOSIS; CALCIUM; ERGOCALCIFEROLS; HYPERPARATHYROIDISM, SECONDARY; MALE; NEPHRECTOMY; PARATHYROID HORMONE; PHOSPHORUS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CALCITRIOL; RENAL INSUFFICIENCY, CHRONIC; UREMIA; VASCULAR RESISTANCE;

EID: 56749156678     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn375     Document Type: Article

References (29)

1. Weiner DE, Tighiouartc H, Amin MG et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15: 1307-1315
2. Tonelli M, Wiebe N, Culleton B et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006; 17: 2034-2047
3. London GM, Marchais SJ, Guerin AP et al. Arteriosclerosis, vascular calcifications and cardiovascular disease in uraemia. Curr Opin Nephrol Hypertens 2005; 14: 525-531
4. Giachelli CM. Vascular calcification mechanisms. J Am Soc Nephrol 2004; 15: 2959-2964
5. Mackey RH, Venkitachalam L, Sutton-Tyrrell K. Calcifications, arterial stiffness and atherosclerosis. Adv Cardiol 2007; 44: 234-244
6. Goodman WG, Goldin J, Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483
7. Oh J, Wunsch R, Turzer M et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 2002; 106: 100-105
8. Lehto S, Niskanen L, Suhonen M et al. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996; 16: 978-983
9. Davies MR, Hruska KA. Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int 2001; 60: 472-479
10. Brown AJ, Dusso AS, Slatopolsky E. Vitamin D analogues for secondary hyperparathyroidism. Nephrol Dial Transplant 2002; 17(Suppl 10): 10-19
11. Martin KJ, Gonzalez EA. Vitamin D analogs: actions and role in the treatment of secondary hyperparathyroidism. Semin Nephrol 2004; 24: 456-459
12. Teng M, Wolf M, Lowrie E et al. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 2003; 349: 446-456
13. Teng M, Wolf M, Ofsthun MN et al. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 2005; 16: 1115-1125
14. Tentori F, Hunt WC, Stidley CA et al. Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 2006; 70: 1858-1865
15. 2, suppresses parathyroid hormone secretion in uraemic rats in the absence of hypercalcaemia. Am J Kidney Dis 1995; 26: 852-860.
16. Mizobuchi M, Finch JL, Martin DR et al. Differential effects of vitamin D receptor activators on vascular calcification in uraemic rats. Kidney Int 2007; 72: 709-715
17. Wolisi GO, Moe SM. The role of vitamin D in vascular calcification in chronic kidney disease. Semin Dial 2005; 18: 307-314
18. Wu-Wong JR, Noonan W, Ma J et al. Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification. J Pharmacol Exp Ther 2006; 318: 90-98
19. Cardus A, Panizo S, Parisi E et al. Differential effects of vitamin D analogs on vascular calcification. J Bone Miner Res 2007; 22: 860-866
20. 3. Nephrol Dial Transplant 2003; 18: 1770-1776
21. Rutsch F, Ruf N, Vaingankar S et al. Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification. Nat Genet 2003; 34: 379-381
22. Ketteler M, Bongartz P, Westenfeld R et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003; 361: 827-833
23. Giachelli CM, Bae N, Almeida M et al. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 1993; 92: 1686-1696
24. Levy RJ, Schoen FJ, Levy JT et al. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehy-depreserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol 1983; 113: 143-155
25. Hunt JL, Fairman R, Mitchell ME et al. Bone formation in carotid plaques: a clinicopathological study. Stroke 2002; 33: 1214-1219
26. Issa LL, Leong GM, Sutherland RL et al. Vitamin D analogue-specific recruitment of vitamin D receptor coactivators. J Bone Miner Res 2002; 17: 879-890
27. Onate SA, Tsai SY, Tsai MJ et al. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 1995; 270: 1354-1357
28. Hong H, Kohli K, Trivedi A et al. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc Natl Acad Sci USA 1996; 93: 4948-4952
29. Li H, Gomes PJ, Chen JD. RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proc Natl Acad Sci USA 1997; 94: 8479-8484